SV2 regulates neurotransmitter release via multiple mechanisms.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  American Journal of Physiology - Cell Physiology

• Publication date

  2010-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/ajpcell.00259.2010PMID 20702688PMCID PMC2980308
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Seletracetam (UCB 44212)

  2011cited by this paper
• SV2 acts via presynaptic calcium to regulate neurotransmitter release.

  2010cited by this paper
• Cotrafficking of SV2 and Synaptotagmin at the Synapse

  2010cited by this paper
• SV2 Renders Primed Synaptic Vesicles Competent for Ca2+-Induced Exocytosis

  2009cited by this paper
• Loss of the Synaptic Vesicle Protein SV2B Results in Reduced Neurotransmission and Altered Synaptic Vesicle Protein Expression in the Retina

  2009cited by this paper
• Effects of levetiracetam on tardive dyskinesia: a randomized, double-blind, placebo-controlled study.

  2008cited by this paper
• Treatment of tardive dyskinesia with levetiracetam in a transplant patient

  2008cited by this paper
• Levetiracetam as adjunctive therapy for refractory anxiety disorders.

  2007cited by this paper
• Levetiracetam: part II, the clinical profile of a novel anticonvulsant drug.

  2007cited by this paper
• A Three-dimensional Model of Human Organic Anion Transporter 1

  2006cited by this paper
• Dramatic response to levetiracetam in post-ischaemic Holmes’ tremor

  2006cited by this paper
• Levetiracetam for treatment-refractory posttraumatic stress disorder.

  2006cited by this paper
• Specific effect of levetiracetam in experimental human pain models *

  2006cited by this paper
• Synaptic Vesicle Protein 2 Enhances Release Probability at Quiescent Synapses

  2006cited by this paper
• Solubilization and immunopurification of rat brain synaptic vesicle protein 2A with maintained binding properties.

  2006cited by this paper
• Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein.

  2006cited by this paper
• Overexpression of proteins in neurons using replication-deficient virus.

  2006cited by this paper
• SV2A and SV2C are not vesicular Ca2+ transporters but control glucose-evoked granule recruitment

  2005cited by this paper
• Levetiracetam in social phobia: a placebo controlled pilot study

  2005cited by this paper
• SV2A and SV2C contain a unique synaptotagmin-binding site.

  2005cited by this paper
• The effect of levetiracetam on essential tremor

  2005cited by this paper
• Levetiracetam as an Adjunctive Analgesic in Neoplastic Plexopathies

  2005cited by this paper
• Levetiracetam in the Treatment of Neuropathic Pain: Three Case Studies

  2004cited by this paper
• The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam.

  2004cited by this paper
• SV2B Regulates Synaptotagmin 1 by Direct Interaction*

  2004cited by this paper
• Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity.

  2004cited by this paper
• Synaptotagmin I Synchronizes Transmitter Release in Mouse Hippocampal Neurons

  2004cited by this paper
• Control of neurotransmitter release by an internal gel matrix in synaptic vesicles

  2003cited by this paper
• Structural Model for 12-Helix Transporters Belonging to the Major Facilitator Superfamily

  2003cited by this paper
• Levetiracetam as a treatment for tardive dyskinesia: A case report

  2003cited by this paper
• Lentivirus-mediated gene transfer into hematopoietic repopulating cells in baboons

  2002cited by this paper
• Synaptotagmin I functions as a calcium regulator of release probability

  2001cited by this paper
• Lentivirus Vectors Encoding Both Central Polypurine Tract and Posttranscriptional Regulatory Element Provide Enhanced Transduction and Transgene Expression

  2001cited by this paper
• SV2 modulates the size of the readily releasable pool of secretory vesicles

  2001cited by this paper
• SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release.

  1999cited by this paper
• Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A).

  1999cited by this paper
• Tryptophan 388 in Putative Transmembrane Segment 10 of the Rat Glucose Transporter Glut1 Is Essential for Glucose Transport*

  1998cited by this paper
• SVOP, an Evolutionarily Conserved Synaptic Vesicle Protein, Suggests Novel Transport Functions of Synaptic Vesicles

  1998cited by this paper
• Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein.

  1996cited by this paper
• The Conserved Motif, GXXX(D/E)(R/K)XG[X](R/K)(R/K), in Hydrophilic Loop 2/3 of the Lactose Permease (*)

  1995cited by this paper
• Synaptotagmin I: a major Ca2+ sensor for transmitter release at a central synapse.

  1994cited by this paper
• Differential expression of synaptic vesicle protein 2 (SV2) isoforms

  1994cited by this paper
• Brain contains two forms of synaptic vesicle protein 2.

  1993cited by this paper
• The SV2 Protein of Synaptic Vesicles Is a Keratan Sulfate Proteoglycan

  1993cited by this paper
• Metal-tetracycline/H+ antiporter of Escherichia coli encoded by transposon Tn10. The role of a conserved sequence motif, GXXXXRXGRR, in a putative cytoplasmic loop between helices 2 and 3.

  1992cited by this paper
• The synaptic vesicle protein SV2 is a novel type of transmembrane transporter.

  1992cited by this paper
• Identification, characterization, and molecular cloning of a novel transporter‐like protein localized to the central nervous system

  1992cited by this paper
• SV2, a brain synaptic vesicle protein homologous to bacterial transporters.

  1992cited by this paper
• Metal-tetracycline/H+ antiporter of Escherichia coli encoded by a transposon Tn10. Histidine 257 plays an essential role in H+ translocation.

  1991cited by this paper

• Synaptic Vesicle Glycoprotein 2A Knockout in Parvalbumin and Somatostatin Interneurons Drives Seizures in the Postnatal Mouse Brain

  2025cites this paper
• New microRNA-based therapies reveal common targets in paediatric medulloblastoma and adult glioblastoma

  2025cites this paper
• Keratan Sulfate Is a Multifunctional Brain Glycosaminoglycan With Instructive Capabilities

  2025cites this paper
• The Biodiversity of KS-Proteoglycans in Cellular Regulation and Tissue Function: Emerging Bioregulatory Roles For Low Sulfation Proteoglycans and Bioconjugates.

  2025cites this paper
• SV2A-PET imaging uncovers cortical synapse loss in multiple sclerosis.

  2025cites this paper
• The Role of Brivaracetam in the Management of Childhood Epilepsy.

  2025cites this paper
• Mechanisms Underlying Allosteric Modulation of Antiseizure Medication Binding to Synaptic Vesicle Protein 2A (SV2A)

  2025cites this paper
• Synaptophysin accelerates synaptic vesicle fusion by expanding the membrane upon neurotransmitter loading

  2025cites this paper
• Glycosaminoglycans, Instructive Biomolecules That Regulate Cellular Activity and Synaptic Neuronal Control of Specific Tissue Functional Properties

  2025cites this paper
• Assessing non-invasive quantitative methods for [18F]SynVesT-1 PET imaging of synaptic vesicle glycoprotein 2A in the rat brain

  2025cites this paper
• Control of Synaptotagmin‐1 Trafficking by SV2A—Mechanism and Consequences for Presynaptic Function and Dysfunction

  2025cites this paper
• Synaptic changes in psychiatric and neurological disorders: state-of-the art of in vivo imaging

  2024cites this paper
• Structural insights into SV2A and the mechanism of racetam anticonvulsants

  2024cites this paper
• Functional genomics screens reveal a role for TBC1D24 and SV2B in antibody-dependent enhancement of dengue virus infection

  2024cites this paper
• Synaptic Vesicle Glycoprotein 2C: a role in Parkinson’s disease

  2024cites this paper
• Effect of Levetiracetam on Oxidant–Antioxidant Activity during Long-Term Temporal Lobe Epilepsy in Rats

  2024cites this paper
• Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression

  2024cites this paper
• Structures of synaptic vesicle protein 2A and 2B bound to anticonvulsants

  2024cites this paper
• Recognition of antiepileptic brivaracetam by synaptic vesicle protein 2A

  2024cites this paper
• Structures of native SV2A reveal the binding mode for tetanus neurotoxin and anti-epileptic racetams

  2024cites this paper
• Functional genomics screens reveal a role for TBC1D24 and SV2B in antibody-dependent enhancement of dengue virus infection

  2024cites this paper
• Structural basis for antiepileptic drugs and botulinum neurotoxin recognition of SV2A

  2024cites this paper
• Pharmacodynamic rationale for the choice of antiseizure medications in the paediatric population

  2024cites this paper
• RREB1 regulates neuronal proteostasis and the microtubule network

  2024cites this paper
• Presynaptic targeting of botulinum neurotoxin type A requires a tripartite PSG‐Syt1‐SV2 plasma membrane nanocluster for synaptic vesicle entry

  2023cites this paper
• Biallelic variants in the synaptic vesicle glycoprotein 2 A are associated with epileptic encephalopathy

  2023cites this paper
• Human placenta-derived mesenchymal stem cells stimulate neuronal regeneration by promoting axon growth and restoring neuronal activity

  2023cites this paper
• Insights to develop tau‐directed therapeutics to protect the synaptic integrity for tauopathies

  2023cites this paper
• miR-218 Promotes Dopaminergic Differentiation and Controls Neuron Excitability and Neurotransmitter Release through the Regulation of a Synaptic-Related Genes Network

  2023cites this paper
• PET imaging of synaptic density in Parkinsonian disorders

  2023cites this paper
• Neuroimaging in psychedelic drug development: past, present, and future

  2023cites this paper
• SV2B defines a subpopulation of synaptic vesicles

  2023cites this paper
• Contingency learning in zebrafish exposed to apomorphine- and levetiracetam

  2023cites this paper
• Synaptic Vesicle Glycoprotein 2A: Features and Functions

  2022cites this paper
• Human fetal membrane-mesenchymal stromal cells generate functional spinal motor neurons in vitro

  2022cites this paper
• Spatio-Temporal Alterations in Synaptic Density During Epileptogenesis in the Rat Brain.

  2022influential citation
• Imaging of Synaptic Density in Neurodegenerative Disorders.

  2022cites this paper
• Single Cell/Nucleus Transcriptomics Comparison in Zebrafish and Humans Reveals Common and Distinct Molecular Responses to Alzheimer’s Disease

  2022cites this paper
• Connectivity Mapping Using a Novel sv2a Loss-of-Function Zebrafish Epilepsy Model as a Powerful Strategy for Anti-epileptic Drug Discovery

  2022cites this paper
• Validation, kinetic modeling, and test-retest reproducibility of [18F]SynVesT-1 for PET imaging of synaptic vesicle glycoprotein 2A in mice

  2022cites this paper
• Spontaneous and TMS-related EEG changes as new biomarkers to measure anti-epileptic drug effects

  2022cites this paper
• A de novo heterozygous rare variant in SV2A causes epilepsy and levetiracetam-induced drug-resistant status epilepticus

  2021cites this paper
• All‐optical monitoring of excitation–secretion coupling demonstrates that SV2A functions downstream of evoked Ca2+ entry

  2021influential citation
• Optimization of Neurite Tracing and Further Characterization of Human Monocyte-Derived-Neuronal-like Cells

  2021cites this paper
• Reductions in Synaptic Vesicle Glycoprotein 2 Isoforms in the Cortex and Hippocampus in a Rat Model of Traumatic Brain Injury

  2021cites this paper
• Biology of Proteoglycans and Associated Glycosaminoglycans

  2021cites this paper
• Synaptic Vesicle Protein 2A Expression in Glutamatergic Terminals Is Associated with the Response to Levetiracetam Treatment

  2021cites this paper
• miR-96 Inhibits SV2C to Promote Depression-Like Behavior and Memory Disorders in Mice

  2021influential citation
• Effects of chronic exposure to haloperidol, olanzapine or lithium on SV2A and NLGN synaptic puncta in the rat frontal cortex.

  2021cites this paper
• Differentiation of two human neuroblastoma cell lines alters SV2 expression patterns

  2021cites this paper
• Changes in the Gene Expression Profiles of the Inferior Colliculus Following Unilateral Cochlear Ablation in Adult Rats

  2021cites this paper
• iTRAQ-Based Proteomic Analysis of Dentate Gyrus in Temporal Lobe Epilepsy With Hippocampal Sclerosis

  2021cites this paper
• The Oscillatory Basis of Working Memory Function and Dysfunction in Epilepsy

  2021cites this paper
• CHAPTER 7

  2020cites this paper
• A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain

  2020cites this paper
• PET Imaging of Synaptic Vesicle Protein 2A

  2020cites this paper
• Distinct synaptic vesicle recycling in inhibitory nerve terminals is coordinated by SV2A.

  2020cites this paper
• Characterization of 3 PET Tracers for Quantification of Mitochondrial and Synaptic Function in Healthy Human Brain: 18F-BCPP-EF, 11C-SA-4503, and 11C-UCB-J

  2020cites this paper
• Safflower Yellow Improves Synaptic Plasticity in APP/PS1 Mice by Regulating Microglia Activation Phenotypes and BDNF/TrkB/ERK Signaling Pathway

  2020cites this paper
• [Brivaracetam-A good alternative for the treatment of muscle cramps].

  2020cites this paper
• Brivaracetam – eine gute Alternative zur Behandlung von Muskelkrämpfen

  2020cites this paper
• Fluid Biomarkers for Synaptic Dysfunction and Loss

  2020cites this paper
• Integration of postmortem amygdala expression profiling, GWAS, and functional cell culture assays: neuroticism-associated synaptic vesicle glycoprotein 2A (SV2A) gene is regulated by miR-133a and miR-218

  2020cites this paper
• Non-toxic fragment of botulinum neurotoxin type A and monomethyl auristatin E conjugate for targeted therapy for neuroendocrine tumors

  2020cites this paper
• Contrasting effects of chronic lithium, haloperidol and olanzapine exposure on synaptic clusters in the rat prefrontal cortex

  2020cites this paper
• Autoradiographic mapping of synaptic vesicle glycoprotein 2A in non-human primate and human brain.

  2020cites this paper
• Analysis of Differential Expression of Synaptic Vesicle Protein 2A in the Adult Rat Brain.

  2019cites this paper
• Keratan sulfate (KS)‐proteoglycans and neuronal regulation in health and disease: the importance of KS‐glycodynamics and interactive capability with neuroregulatory ligands

  2019cites this paper
• Synaptic vesicle protein 2: A multi-faceted regulator of secretion.

  2019cites this paper
• Functional Consequences of Keratan Sulfate Sulfation in Electrosensory Tissues and in Neuronal Regulation

  2019cites this paper
• Levetiracetam inhibits SV2A-synaptotagmin interaction at synapses that lack SV2B

  2019cites this paper
• Validation and noninvasive kinetic modeling of [11C]UCB-J PET imaging in mice

  2019cites this paper
• Mutant Huntingtin Causes a Selective Decrease in the Expression of Synaptic Vesicle Protein 2C

  2018cites this paper
• Single cell analyses of the effects of Amyloid-beta42 and Interleukin-4 on neural stem/progenitor cell plasticity in adult zebrafish brain

  2018cites this paper
• Keratan sulfate, a complex glycosaminoglycan with unique functional capability

  2018cites this paper
• Synaptic vesicle 2C and its synaptic-related function.

  2017cites this paper
• Pharmacokinetic Characterization of [18F]UCB-H PET Radiopharmaceutical in the Rat Brain.

  2017cites this paper
• Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease

  2017cites this paper
• Two Feet on the Membrane: Uptake of Clostridial Neurotoxins.

  2017cites this paper
• Puzzling Out Synaptic Vesicle 2 Family Members Functions

  2017influential citation
• Kinetic evaluation and test–retest reproducibility of [11C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans

  2017cites this paper
• Differentiated Human SH-SY5Y Cells Provide a Reductionist Model of Herpes Simplex Virus 1 Neurotropism

  2017cites this paper
• Evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein

  2017cites this paper
• Therapeutic Role of Synaptic Vesicle Glycoprotein 2A (SV2A) in Modulating Epileptogenesis.

  2017cites this paper
• Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer’s Disease

  2017cites this paper
• King’s Research

  2016cites this paper
• A comparison of four antiepileptic drugs in status epilepticus: experience from India

  2016cites this paper
• A Missense Mutation of the Gene Encoding Synaptic Vesicle Glycoprotein 2A (SV2A) Confers Seizure Susceptibility by Disrupting Amygdalar Synaptic GABA Release

  2016influential citation
• King’s Research

  2016cites this paper
• Synaptic Vesicle Protein 2A as a Novel Pharmacological Target with Broad Potential for New Antiepileptic Drugs

  2016cites this paper
• Synaptotagmin-2, and -1, linked to neurotransmission impairment and vulnerability in Spinal Muscular Atrophy.

  2016cites this paper
• Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson’s disease

  2016cites this paper
• Lamotrigine and levetiracetam exert a similar modulation of TMS‐evoked EEG potentials

  2016cites this paper
• Synaptic vesicle glycoprotein 2A (SV2A) regulates kindling epileptogenesis via GABAergic neurotransmission

  2016cites this paper
• Levetiracetam prophylaxis ameliorates seizure epileptogenesis after fluid percussion injury.

  2016cites this paper
• Familial Dysautonomia (FD) Human Embryonic Stem Cell Derived PNS Neurons Reveal that Synaptic Vesicular and Neuronal Transport Genes Are Directly or Indirectly Affected by IKBKAP Downregulation

  2015cites this paper
• Títol del treball:

  2015influential citation
• Exploring the Interaction of SV 2 A with Racetams Using Homology Modelling , Molecular Dynamics and Site-Directed Mutagenesis

  2015cites this paper
• Homozygous Mutation in Synaptic Vesicle Glycoprotein 2A Gene Results in Intractable Epilepsy, Involuntary Movements, Microcephaly, and Developmental and Growth Retardation.

  2015cites this paper
• Control of Axon Guidance and Neurotransmitter Phenotype of dB1 Hindbrain Interneurons by Lim-HD Code

  2015cites this paper